. Author manuscript; available in PMC: 2014 Aug 4.

Published in final edited form as: Rev Cardiovasc Med. 2014;15(0 1):S1–S8. doi: 10.3908/ricm15S1S002

Table 1. Summary of epidemiologic studies on HIV and CHD.

Study	Year	N (HIV)	Control group	Female (%)	Age HIV	Time period	HIV f/u (yrs)	Primary Result	Effect Size
Kaiser⁵	2002	4159	Random sample Kaiser members	0	Mean 44	1996- 2001	4.1	↑ MI and CHD in HIV vs. controls	1.5 (MI) 1.7 (CHD)
CA Medicaid⁶	2003	28513	Patients enrolled in CA Medicaid > 1 year	27	46% M and 35% F age 35-44	1994- 2000	2.5	↑ CHD in HIV (age 18-33) vs. controls	2.06
FHDH⁷	2003	34976	Estimated rates from French male general population	0	Mean 38	1996- 1999	2.8	↑ MI in HIV with PI exposure >18 months vs. general population	1.5 (PI 18-29 months) 2.9 (PI ≥ 30 months)
Partners HIV cohort⁸	2007	3851	Controls from health care system-based data registry	30	Median 38	1996- 2004	4.5	↑ incident MI in HIV vs. controls	1.75
Danish HIV cohort⁹	2007	3953	Population-based control group matched 95:1 on sex, age, residence	23	Median 37	1995- 2004	5.2	↑ first hospitalization for CHD in HIV on ART vs. controls	2.12
FHDH¹⁰	2010	74958	Three population- based French registries	11	Median 47	2000- 2006	--	↑ MI in HIV vs. 3 population registries	1.5
Quebec RAMQ database¹¹	2011	7053	Control group on sex, age, entry date, duration insurance	22	Median 37	1985- 2007	4.2	↑ MI in HIV vs. 4:1 matched controls	2.11
VACS cohort¹³	2013	27350	Controls from VACS matched on age, race, site, calendar year	3	Median 49	2003- 2009	5.9	↑ MI in HIV vs. 2:1 matched control	1.48
Kaiser¹⁴	2013	22081	HIV-uninfected Kaiser members	9	40% age 35-44	1996- 2009	4.5	↑ MI in HIV vs. controls	1.4